The future of neuromodulation


Why the industry needs to shift to high-volume, low-cost, disease-management solutions Miniaturised implants providing targeted nerve stimulation – perhaps even put in place via a simple injection in the doctor’s surgery. That’s the vision for the future of neuromodulation painted by product design and development firm Cambridge Consultants. The company says demand for mass-market therapies …




Continue reading